Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Federal Trade Commission
Accenture
Cipla
Chubb
Mallinckrodt

Generated: August 17, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 203844

  Try a free trial


See Plans and Pricing

« Back to Dashboard

NDA 203844 describes RIVASTIGMINE TARTRATE, which is a drug marketed by Alembic Pharms Ltd, Apotex Inc, Aurobindo Pharma Ltd, Cadila Pharms Ltd, Chartwell Rx, Dr Reddys Labs Inc, Macleods Pharms Ltd, Orchid Hlthcare, Sun Pharm, and Watson Labs, and is included in ten NDAs. It is available from fifteen suppliers. Additional details are available on the RIVASTIGMINE TARTRATE profile page.

The generic ingredient in RIVASTIGMINE TARTRATE is rivastigmine tartrate. There are thirty-two drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the rivastigmine tartrate profile page.
Summary for 203844
Tradename:RIVASTIGMINE TARTRATE
Applicant:Cadila Pharms Ltd
Ingredient:rivastigmine tartrate
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 203844
Mechanism of ActionCholinesterase Inhibitors
Suppliers and Packaging for NDA: 203844
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
RIVASTIGMINE TARTRATE rivastigmine tartrate CAPSULE;ORAL 203844 ANDA Cadila Pharmaceuticals Limited 71209-012 71209-012-03 60 CAPSULE in 1 BOTTLE (71209-012-03)
RIVASTIGMINE TARTRATE rivastigmine tartrate CAPSULE;ORAL 203844 ANDA Cadila Pharmaceuticals Limited 71209-012 71209-012-10 500 CAPSULE in 1 BOTTLE (71209-012-10)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrengthEQ 1.5MG BASE
Approval Date:Feb 13, 2017TE:ABRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrengthEQ 3MG BASE
Approval Date:Feb 13, 2017TE:ABRLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrengthEQ 4.5MG BASE
Approval Date:Feb 13, 2017TE:ABRLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Julphar
Colorcon
US Department of Justice
Deloitte
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.